[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342897-105":59,"doc-detail-342897-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","design-of-pd-l1-targeted-lipid-nanoparticles-to-turn-on-pten-for-efficient-cancer-therapy","Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy","","Lipid nanoparticles (LNPs) enable efficient mRNA delivery but often accumulate in the liver or spleen, limiting tissue-specific immunotherapy. A streamlined strategy conjugates PD-L1 binding peptides to PEGylated lipids via a copper-free click reaction and incorporates them directly into LNPs (Pep LNPs). Pep LNPs show strong interaction with PD-L1 proteins and preferential uptake in PD-L1 overexpressing cancer cells in vitro and in vivo. Delivering PTEN-encoding mRNA restores tumor suppressor function in PTEN-deficient triple-negative breast cancers, promoting autophagy-mediated immunogenic cell death in 4T1 tumors and effective antitumor immune responses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/design-of-pd-l1-targeted-lipid-nanoparticles-to-turn-on-pten-for-efficient-cancer-therapy/342897/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/design-of-pd-l1-targeted-lipid-nanoparticles-to-turn-on-pten-for-efficient-cancer-therapy/342897.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How are PD-L1-targeted Pep LNPs constructed in the study?","Question",{"text":112,"@type":113},"PD-L1 binding peptides are conjugated to PEGylated lipids through a copper-free click reaction and then directly incorporated into the LNP composition to form Pep LNPs.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does PD-L1 targeting play in Pep LNP performance?",{"text":117,"@type":113},"Pep LNPs interact robustly with PD-L1 proteins, enabling uptake into PD-L1 overexpressing cancer cells both in vitro and in vivo.",{"name":119,"@type":110,"acceptedAnswer":120},"How does PTEN mRNA delivery using Pep LNPs affect triple-negative breast cancer?",{"text":121,"@type":113},"Pep LNPs loaded with PTEN mRNA promote autophagy-mediated immunogenic cell death in 4T1 tumors, leading to effective anticancer immune responses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342897,1790208715,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \nDesign of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Eﬃcient Cancer Therapy  \nYelee Kim, Jiwoong Choi, Eun Hye Kim, Wonbeom Park, Hochung Jang, Yeongji Jang, Sung-Gil Chi, Dae-Hyuk Kweon, Kyuri Lee, Sun Hwa Kim,* and Yoosoo Yang*  \nLipid nanoparticles (LNPs) exhibit remarkable mRNA delivery eﬃciency, yet their majority accumulate in the liver or spleen after injection. Tissue-speciﬁcmRNA delivery can be achieved through modulating LNP properties, such as tuning PEGylation or varying lipid components systematically. In this paper, a streamlined method is used for incorporating tumor-targeting peptides into the LNPs; the programmed death ligand 1 (PD-L1) binding peptides are conjugated to PEGylated lipids via a copper-free click reaction, and directly incorporated into the LNP composition (Pep LNPs). Notably, Pep LNPs display robust interaction with PD-L1 proteins, which leads to the uptake of LNPs into PD-L1 overexpressing cancer cells both in vitro and in vivo. To evaluate anticancer immunotherapy mediated by restoring tumor suppressor, mRNA encoding phosphatase and tensin homolog (PTEN) is delivered via Pep LNPs to PTEN-deﬁcient triple-negative breast cancers (TNBCs). Pep LNPs loaded with PTEN mRNA speciﬁcally promotes autophagy-mediated immunogenic cell death in 4T1 tumors, resulting in eﬀective anticancer immune responses. This study highlights the potential of tumor-targeted LNPs for mRNA-based cancer therapy.  \nin the context of cancer immunotherapy.[2] mRNA-based cancer immunotherapy, involving vaccines encoding tumor antigens and immune modulators, has shown promise in both preclinical and clinical studies. [3] Furthermore, recent endeavors have emerged to directly address cancer by introducing mRNA-encoding functional proteins to replace missing or defective endogenous ones. [4] For example, delivering mRNAs that encode tumor suppressor genes, such as phosphatase and tensin homolog (PTEN) or p53, to cancer cells with signiﬁcant deﬁciencies has proven eﬀective in reducing tumorigenesis by restoring their normal cellular functions. [5]  \nTo unlock the full therapeutic potential of mRNA, lipid nanoparticles (LNPs) have risen as the most advanced nanocarriers, exempliﬁed by the FDA’s approval ofCOVID- 19 mRNA vaccines. [6] Numerous mRNA therapeutics utilizing LNP systems are undergoing clinical trials for a range of human  \n1. Introduction  \nSigniﬁcant advances in mRNA technology have enabled the rapid and eﬃcient programmed design and manufacturing of functional proteins. [1] This versatility has driven the use of mRNA in diverse immunotherapeutic approaches, particularly  \ndiseases, including cancer.[7] Despite the growing utilization of LNPs in mRNA-based therapies,[8] achieving in vivo delivery to speciﬁc tissues beyond liver targeting remains a formidable challenge. [9]  \nTo overcome this issue and eﬀectively transport mRNA to the tumor microenvironment (TME), researchers have devoted signiﬁcant eﬀorts to engineering the surface of LNPs. [9] This  \nY. Kim, J. Choi, E. H. Kim, H. Jang, Y. Jang, S. H. Kim, Y. Yang Biomedical Research Division  \nKorea Institute of Science and Technology (KIST) Seoul 02792, Republic of Korea  \nE-mail: [sunkim@kist. re.kr](sunkim@kist. re.kr); [ysyang@kist. re.kr](ysyang@kist. re.kr)  \nY. Kim, E. H. Kim, Y. Jang, S.-G. Chi Department of Life Sciences Korea University  \nSeoul 02841, Republic of Korea  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202309917](https://doi.org/10.1002/advs.202309917)[ ](https://doi.org/10.1002/advs.202309917)© 2024 The Authors. Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202309917  \nW. ","cbCaicsntusi3R1s","https://ap.wps.com/l/cbCaicsntusi3R1s","pdf",6570009,15,"English","# Introduction\n## mRNA therapeutics and lipid nanoparticles\n## Tissue-specific delivery challenges\n## Tumor microenvironment targeting via LNP engineering\n# Results (from figure context)\n## Pep LNP design and click-conjugation strategy\n## PD-L1 binding, uptake, and downstream immunotherapy effects","[{\"question\":\"How are PD-L1-targeted Pep LNPs constructed in the study?\",\"answer\":\"PD-L1 binding peptides are conjugated to PEGylated lipids through a copper-free click reaction and then directly incorporated into the LNP composition to form Pep LNPs.\"},{\"question\":\"What role does PD-L1 targeting play in Pep LNP performance?\",\"answer\":\"Pep LNPs interact robustly with PD-L1 proteins, enabling uptake into PD-L1 overexpressing cancer cells both in vitro and in vivo.\"},{\"question\":\"How does PTEN mRNA delivery using Pep LNPs affect triple-negative breast cancer?\",\"answer\":\"Pep LNPs loaded with PTEN mRNA promote autophagy-mediated immunogenic cell death in 4T1 tumors, leading to effective anticancer immune responses.\"}]","Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy | PDF",1790048722,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c98d1c3c291f958c2985bac889867865.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b8673bcbeb0acfd8b568f7c15adf751.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/683639ae7290b91409303615f50c1129.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/016c7685b61a64dd2e15963df50f7a09.webp",980,1287]